Inventor · disambiguated record
Gordon Wilkie
Also filed as: WILKIE GORDON · WILKIE GORDON D
5 granted patents·6 pending applications·10 citations·filing 2009–2023
74Inventor score
Top patents by PatentIndex Score
11 records- 0191US11999744B2Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of makingBLUEPRINT MEDICINES CORP·Filed 2023·Granted Jun 4, 2024·2 cites·14 claims
- 0291USRE47797EIntermediates for the preparation of analogs of halichondrin BEISAI R&D MAN CO LTD·Filed 2018·Granted Jan 7, 2020·7 cites·15 claims
- 0384US12060354B2Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of makingBLUEPRINT MEDICINES CORP·Filed 2021·Granted Aug 13, 2024·1 cites·14 claims
- 0478US11964980B2Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1- f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of makingBLUEPRINT MEDICINES CORP·Filed 2022·Granted Apr 23, 2024·0 cites·7 claims
- 0558US2012029213A1Intermediates for the preparation of analogs of halichondrin bAUSTAD BRIAN·Filed 2011·Application pending·0 cites
- 0654US12448366B2Solid forms of pralsetinibRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Oct 21, 2025·0 cites·19 claims
- 0754US2011172427A1Process for preparing certain cinnamide compoundsEISAI R&D MAN CO LTD·Filed 2009·Application pending·0 cites
- 0852US2024059672A1Method of preparing pralsetinibBLUEPRINT MEDICINES CORP·Filed 2021·Application pending·0 cites
- 0950US2023203009A1Pralsetinib pharmaceutical compositionsBLUEPRINT MEDICINES CORP·Filed 2021·Application pending·0 cites
- 1047US2022281879A1Salt and crystal forms of an activin receptor-like kinase inhibitorBLUEPRINT MEDICINES CORP·Filed 2020·Application pending·0 cites
- 1145US2022396576A1Process for preparing an activin receptor-like kinase inhibitorBLUEPRINT MEDICINES CORP·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →